LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Health Net Inc. announced Thursday that it will be acquired by Centene Corp. in a cash and stock deal valued at $6.8 billion.
An investment from Allscripts Healthcare Solutions values Patrick Soon-Shiong’s health care IT firm NantHealth at $2 billion.
Walt Disney Co. has settled a lawsuit alleging copyright infringement involving the trailer for its 2013 animated hit “Frozen.”
Ritter Pharmaceuticals Inc., developer of drugs to treat lactose intolerance, debuted on the Nasdaq today under the symbol RTTR.
NantCell, the immuno-oncology subsidiary of billionaire Patrick Soon-Shiong’s growing NantWorks health care technology empire, has acquired tissue and stem cell engineering firm VivaBioCell. Terms of the deal were not disclosed.
Biotech firm Kite Pharma Inc. announced Monday that it will partner with leading immunotherapy developer Bluebird Bio Inc. of Cambridge, Mass. to develop and commercialize drugs directed against a cancer-causing strain of the human papillomavirus, or HPV.
Monday Rundown: New CEO for Long Beach Hospitals, Gulfstream Accountant Sentenced for Embezzlement, Tutor Perini to Build Philadelphia Hotel
MemorialCare Health System has promoted John Bishop, chief financial officer of Long Beach Memorial hospital, Miller Children’s & Women’s Hospital Long Beach, Community Hospital Long Beach and Seaside Health Plan in Long Beach, to chief executive.
The Department of Justice announced Thursday it has charged eight people in Los Angeles with bilking Medicare out of about $66 million.
Kythera Biopharmaceuticals, Inc. will be acquired by Allergan plc in a $2.1 billion buyout announced Wednesday.
Wednesday Rundown: Wage Hike Almost Official, Sundance Cinema Selling, Arrowhead Drug Gets ‘Orphan’ Incentives
Council OKs Wage Hike It’s almost officially official: The Los Angeles City Council has given final approval to a minimum wage hike in the city, sending the measure to the mayor’s desk.
A regulatory advisory panel on Wednesday recommended approval for Repatha, a new cholesterol drug from Amgen Inc., although use should be limited to patients with high risk of heart disease.
Health regulators have decided a new drug from Amgen Inc. reduces “bad” cholesterol, but they aren’t sure it’s for everyone.
Puma Biotechnology Inc. got a mixed reception from physicians Monday morning after the company shared additional data from its pivotal breast cancer drug trial at the American Society of Clinical Oncology’s annual meeting in Chicago.
Children’s Hospital Los Angeles on Monday opened a new outpatient care center in Encino, the Los Feliz institutions fifth outpost opened over the past few years. Opening satellite sites is a popular practice among local hospitals, which see them as a cheaper way to expand their services while also helping bring in more patients who are privately insured. See more on the hospital’s strategy in the latest edition of the Business Journal.
Amgen Inc. will expand its collaboration with Merck on research seeking a cure for a special type of head and neck cancer, the company announced Friday.